number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Impact the CVS GLP-1 formulary change: Trends in prescribing Real‐world titration, persistence & weight

A pivotal safety analysis of the STEP trials found that the overall safety profile is well-characterized and serious adverse events are rare (Wilding et al., New England Journal of Medicine , 2021)

Previous clinical trials have reported that the phenocopying phenomenon was observed in 67% of male subjects (O'Mathna et al., 2008) and in 100% of the females (Yubero-Lahoz et al., 2011)

Results from a cross-sectional population study

GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are medications that can effectively manage appetite and food intake, help improve blood sugar levels, and aid in weight loss

These timelines reflect real-world outcomes from patients using licensed 503A compounded medications across all 50 states, not laboratory conditions